When did MYRIAD GENETICS INC (MYGN) report earnings last quarter?
MYRIAD GENETICS INC (MYGN) last reported earnings on 2/23/2026.
MYRIAD GENETICS INC (MYGN) Earnings History & Surprises
NASDAQ:MYGN • US62855J1043
Current stock price
4.75 USD
+0.16 (+3.49%)
At close:
4.75 USD
0 (0%)
After Hours:
MYGN Earnings overview
Past quarterly earnings results for MYRIAD GENETICS INC (MYGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.07
- Revenue Estimate
- 206.43M
Last Reported
Most Recent- Release Date
- Feb 23, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.04
- EPS Surprise
- 368.23%
- Revenue Surprise
- -0.81%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.04 | -0.01 | 368.23% | 33.33% | 209.8M | 211.51M | -0.81% | -0.38% |
| Q3 2025 | 0.00 | -0.01 | 100.00% | -100.00% | 205.7M | 208.99M | -1.57% | -3.56% |
| Q2 2025 | 0.05 | -0.01 | 627.66% | - | 213.1M | 205.91M | 3.49% | 0.76% |
| Q1 2025 | -0.03 | -0.06 | 49.87% | -200.00% | 195.9M | 204.58M | -4.24% | -3.12% |
| Q4 2024 | 0.03 | 0.03 | -2.90% | -25.00% | 210.6M | 215.85M | -2.43% | 7.12% |
| Q3 2024 | 0.06 | 0.02 | 205.26% | 300.00% | 213.3M | 214.94M | -0.76% | 11.15% |
| Q2 2024 | 0.05 | -0.01 | 500.81% | 162.50% | 211.5M | 209.05M | 1.17% | 15.26% |
| Q1 2024 | -0.01 | -0.11 | 90.66% | 95.24% | 202.2M | 197.38M | 2.44% | 11.59% |
| Q4 2023 | 0.04 | 0.01 | 208.06% | 133.33% | 196.6M | 198.68M | -1.05% | 10.57% |
| Q3 2023 | -0.03 | -0.08 | 63.74% | 84.21% | 191.9M | 182.82M | 4.97% | 22.70% |
| Q2 2023 | -0.08 | -0.09 | 7.73% | -300.00% | 183.5M | 190.87M | -3.86% | 2.34% |
| Q1 2023 | -0.21 | -0.20 | -6.49% | -600.00% | 181.2M | 174.98M | 3.55% | 9.88% |
| Q4 2022 | -0.12 | -0.17 | 27.97% | -500.00% | 177.8M | 172.85M | 2.86% | 10.57% |
| Q3 2022 | -0.19 | -0.06 | -210.46% | -850.00% | 156.4M | 173.5M | -9.86% | -6.52% |
| Q2 2022 | 0.04 | 0.01 | 292.16% | -66.67% | 179.3M | 174.42M | 2.80% | -5.33% |
| Q1 2022 | -0.03 | -0.07 | 56.19% | 50.00% | 164.9M | 159.76M | 3.22% | -4.74% |
| Q4 2021 | -0.02 | -0.02 | 15.95% | 83.33% | 160.8M | 166.67M | -3.52% | 4.01% |
| Q3 2021 | -0.02 | -0.02 | 1.96% | 93.41% | 167.3M | 168.34M | -0.62% | 15.22% |
| Q2 2021 | 0.12 | -0.09 | 235.38% | 125.27% | 189.4M | 168.42M | 12.46% | 103.22% |
| Q1 2021 | -0.06 | -0.14 | 57.60% | -884.31% | 173.1M | 159.33M | 8.64% | 5.55% |
| Q4 2020 | -0.12 | -0.13 | 4.61% | - | 154.6M | 153.4M | 0.78% | - |
| Q3 2020 | -0.30 | - | - | 145.2M | 137.242M | 5.80% | - | |
| Q2 2020 | -0.47 | - | - | 93.2M | 95.26M | -2.16% | - | |
| Q1 2020 | 0.01 | - | - | 164M | 169.893M | -3.47% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
286.44%
Max EPS beat (4)
627.66%
Min EPS beat (4)
49.87%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-0.78%
Max Revenue beat (4)
3.49%
Min Revenue beat (4)
-4.24%
Analysis
In the last 4 quarters, MYGN has consistently beaten EPS estimates in all releases
MYGN has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, MYGN has beaten the EPS estimates by 286.4% on average.
In the last 4 quarters, MYGN reported -0.8% below the revenue estimates on average.
Related analysis
MYRIAD GENETICS INC / MYGN Earnings FAQ
Did MYGN stock beat earnings estimates in the most recent quarter?
MYRIAD GENETICS INC (MYGN) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does MYGN stock beat earnings estimates?
In the last 4 quarters, MYRIAD GENETICS INC (MYGN) has beaten EPS estimates in 4 out of 4 releases.